CRONOS GROUP INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
CRONOS GROUP INC. (CRON) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 8.57 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2026-08-06
- CRONOS GROUP INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2026-06-30 was 8.57K shares.
- CRONOS GROUP INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2026-03-31 was 110.92K shares, a 38.98% decline year-over-year.
- CRONOS GROUP INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-09-30 was 6.28K shares, a 97.84% decline year-over-year.
- CRONOS GROUP INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-06-30 was 0.00 shares.
- CRONOS GROUP INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- CRONOS GROUP INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2024 was 255.38K shares.
- CRONOS GROUP INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2023 was 0.00 shares.
- CRONOS GROUP INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2022 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | 8.57K shares 10-Q · filed 2026-08-06 | 59.74K shares 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 110.92K shares 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 6.28K shares 10-Q · filed 2025-11-06 | 0.00 shares 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 0.00 shares 10-Q · filed 2026-08-06 | 0.00 shares 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 181.76K shares 10-Q · filed 2026-05-11 | |||
| 2024-12-31 | 255.38K shares 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 290.73K shares 10-Q · filed 2025-11-06 | 0.00 shares 10-Q · filed 2025-11-06 | ||
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 0.00 shares 10-K · filed 2026-02-26 | |||
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-11-12 | 0.00 shares 10-Q · filed 2024-11-12 | ||
| 2022-12-31 | 0.00 shares 10-K · filed 2025-02-27 | |||
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-07 | 0.00 shares 10-Q · filed 2022-11-07 | ||
| 2021-12-31 | 0.00 shares 10-K · filed 2023-02-28 | |||
| 2021-09-30 | 107.94K shares 10-Q · filed 2022-11-07 | 0.00 shares 10-Q · filed 2022-11-07 | ||
| 2020-12-31 | 0.00 shares 10-K · filed 2023-02-28 | |||
| 2020-09-30 | 81.57K shares 10-Q · filed 2022-02-18 | 30.07K shares 10-Q · filed 2022-02-18 | ||
| 2019-12-31 | 1.88M shares 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |